celecoxib has been researched along with chondroitin sulfates in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 17 (73.91) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Iimoto, S; Shimizu, A; Takahashi, T; Watanabe, S; Yamamoto, H | 1 |
| Bingham, CO; Bradley, JD; Brandt, KD; Clegg, DO; Cush, JJ; Furst, DE; Harris, CL; Hooper, MM; Jackson, CG; Klein, MA; Lane, NE; Molitor, JA; Moreland, LW; Moskowitz, RW; O'Dell, JR; Oddis, CV; Reda, DJ; Sawitzke, AD; Schnitzer, TJ; Schumacher, HR; Shi, H; Weisman, MH; Williams, HJ; Wolfe, F; Yocum, DE | 1 |
| Traynor, K | 1 |
| Clegg, DO; Hochberg, MC | 1 |
| Bingham, CO; Bradley, JD; Clegg, DO; Dunlop, DD; Finco, MF; Furst, DE; Harris, CL; Jackson, CG; Lane, NE; Lisse, J; Moskowitz, RW; Oddis, CV; Reda, DJ; Sawitzke, AD; Shi, H; Silver, D; Singer, NG; Williams, HJ; Wolfe, F | 1 |
| Kvien, TK; Olsen, IC; Uhlig, T | 1 |
| Arden, N; Berenbaum, F; Blanco, FJ; Castillo, JR; Conaghan, PG; Doménech, G; du Souich, P; Henrotin, Y; Hochberg, MC; Martel-Pelletier, J; Möller, I; Monfort, J; Pap, T; Pelletier, JP; Richette, P; Sawitzke, A | 1 |
| Onuora, S | 1 |
| Danilov, AB; Grigorenko, NV | 1 |
| Plate, A | 1 |
| Abram, F; Beaulieu, AD; Bessette, L; de Brum-Fernandes, AJ; Delorme, P; Dorais, M; Martel-Pelletier, J; Morin, F; Paiement, P; Pelletier, JP; Raynauld, JP | 1 |
| Abram, F; Delorme, P; Dodin, P; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP | 1 |
| Blicharski, T; Dudler, J; Pavelka, K; Reginster, JY | 1 |
| Marcus, DM | 1 |
| Abram, F; Delorme, P; Martel-Pelletier, J; Mineau, F; Paiement, P; Pelletier, JP; Raynauld, JP | 1 |
| Kardeş, S | 1 |
| Herrero-Beaumont, G; Largo, R | 1 |
| Reginster, JL | 1 |
| Lee, YH | 1 |
| Reginster, JY | 1 |
| Bruyère, O | 1 |
| Bruyère, O; Dardenne, N; Donneau, AF; Reginster, JY | 1 |
1 review(s) available for celecoxib and chondroitin sulfates
| Article | Year |
|---|---|
[An antinociceptive effect of chondroprotectors: a myth or a reality?].
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Celecoxib; Chondroitin Sulfates; Chronic Pain; Cyclooxygenase 2 Inhibitors; Cytokines; Drug Combinations; Glucosamine; Humans; Interleukin-10; Interleukin-6; Low Back Pain; Nociceptive Pain; Osteoarthritis; Randomized Controlled Trials as Topic; Syndrome | 2015 |
10 trial(s) available for celecoxib and chondroitin sulfates
| Article | Year |
|---|---|
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin Sulfates; Double-Blind Method; Drug Therapy, Combination; Female; Glucosamine; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Pyrazoles; Severity of Illness Index; Sulfonamides; Treatment Outcome | 2006 |
Potential effects of chondroitin sulfate on joint swelling: a GAIT report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin Sulfates; Double-Blind Method; Female; Glucosamine; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pyrazoles; Radiography; Sulfonamides; Treatment Outcome | 2008 |
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT.
Topics: Aged; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Drug Combinations; Female; Glucosamine; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Radiography; Sulfonamides; Treatment Outcome | 2010 |
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.
Topics: Aged; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Combinations; Edema; Female; Glucosamine; Humans; Male; Middle Aged; Musculoskeletal Pain; Osteoarthritis, Knee; Pain Measurement; Quality of Life; Treatment Outcome | 2016 |
[Not Available].
Topics: Aged; Celecoxib; Chondroitin Sulfates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucosamine; Humans; Male; Middle Aged; Osteoarthritis, Knee | 2016 |
Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.
Topics: Aged; Cartilage, Articular; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteoarthritis, Knee; Treatment Outcome | 2016 |
Bone curvature changes can predict the impact of treatment on cartilage volume loss in knee osteoarthritis: data from a 2-year clinical trial.
Topics: Adult; Aged; Bone Diseases; Cartilage Diseases; Cartilage, Articular; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Organ Size; Osteoarthritis, Knee | 2017 |
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT).
Topics: Aged; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Treatment Outcome | 2017 |
Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study.
Topics: Adult; Aged; Biomarkers; Cartilage, Articular; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteoarthritis, Knee; Treatment Outcome | 2017 |
Pharmaceutical-grade chondroitin sulfate in the management of knee osteoarthritis.
Topics: Administration, Oral; Aged; Celecoxib; Chondroitin Sulfates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain; Placebo Effect; Treatment Outcome | 2018 |
12 other study(ies) available for celecoxib and chondroitin sulfates
| Article | Year |
|---|---|
The influence of Celecoxib on matrix synthesis by chondrocytes under mechanical stress in vitro.
Topics: Aggrecans; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Matrix; Celecoxib; Cells, Cultured; Chondrocytes; Chondroitin Sulfates; Collagen Type II; Cyclooxygenase 2; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Intramolecular Oxidoreductases; Lectins, C-Type; Nitric Oxide; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Proteoglycans; Pyrazoles; Rats; Rats, Wistar; RNA, Messenger; Stress, Mechanical; Sulfonamides | 2005 |
Arthritis supplement combination falls short in study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin Sulfates; Clinical Trials as Topic; Dietary Supplements; Glucosamine; Humans; Osteoarthritis; Pain; Pyrazoles; Sulfonamides; Treatment Outcome | 2006 |
The NIH Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT).
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin Sulfates; Clinical Trials as Topic; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Glucosamine; Humans; Male; Middle Aged; National Institutes of Health (U.S.); Osteoarthritis, Knee; Pain; Pyrazoles; Sulfonamides; Treatment Outcome; United States | 2008 |
Consequences of handling missing data for treatment response in osteoarthritis: a simulation study.
Topics: Bias; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Data Interpretation, Statistical; Glucosamine; Humans; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Randomized Controlled Trials as Topic; Research Design; Sulfonamides; Treatment Outcome | 2012 |
Clinical trials: Glucosamine-chondroitin combo improves knee OA pain.
Topics: Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Edema; Female; Glucosamine; Humans; Male; Osteoarthritis, Knee | 2015 |
Chondroitin sulfate for knee osteoarthritis.
Topics: Celecoxib; Chondroitin Sulfates; Glucosamine; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
Comment on CONCEPT by Reginster
Topics: Celecoxib; Chondroitin Sulfates; Data Analysis; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
Osteoarthritis: Chondroitin sulfate - CONCEPT clear, uncertainties unchanged.
Topics: Celecoxib; Chondroitin Sulfates; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2017 |
CONCEPT provides robust evidence that chondroitin sulfate is superior to placebo and similar to celecoxib in the symptomatic management of osteoarthritis.
Topics: Celecoxib; Chondroitin Sulfates; Glucosamine; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
Chondroitin sulfate is superior to placebo in symptomatic knee osteoarthritis.
Topics: Celecoxib; Chondroitin Sulfates; Double-Blind Method; Glucosamine; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
Differentiation between various Chondroitin sulfate formulations in symptomatic knee osteoarthritis.
Topics: Celecoxib; Chondroitin Sulfates; Glucosamine; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial.
Topics: Celecoxib; Chondroitin Sulfates; Double-Blind Method; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations; Treatment Outcome | 2020 |